Test Drive Our New Site! We have some improvements in the works that we're excited for you to experience. Click here to try our new, faster, mobile friendly beta site. We will be maintaining our current version of the site thru the end of 2024, so you can switch back as our improvements continue.
Legislation Quick Search
04/19/2024 09:11 AM
Pennsylvania House of Representatives
https://www.legis.state.pa.us/cfdocs/legis/CSM/showMemoPublic.cfm?chamber=H&SPick=20150&cosponId=20217
Share:
Home / House Co-Sponsorship Memoranda

House Co-Sponsorship Memoranda

Subscribe to PaLegis Notifications
NEW!

Subscribe to receive notifications of new Co-Sponsorship Memos circulated

By Member | By Date | Keyword Search


House of Representatives
Session of 2015 - 2016 Regular Session

MEMORANDUM

Posted: May 11, 2016 12:43 PM
From: Representative Doyle Heffley
To: All House members
Subject: Narcan in Recovery Houses - Heffley
 
Due to the unfortunate overdose death of an individual in my legislative district who resided in a recovery house, I plan to introduce legislation addressing the use of Naloxone in recovery houses. Naloxone (sold under the brand name Narcan) is a medication used to block the effects of opioids, particularly in overdose situations. Law enforcement officers and first responders as well as many individuals living with or around a person addicted to opioids commonly carry this life saving medication and are trained to administer it.

My legislation will mandate that recovery houses receiving public funding will be required to keep Naloxone on site as well as have trained individuals present to administer the medication properly. The result will be a decrease in the number of opioid related overdose deaths in recovery houses here in Pennsylvania.

Please join me in co-sponsoring this important piece of legislation.

View Attachment


Introduced as HB2128